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Pharmacist interventionAbstract Objective: To describe the role of Clinical Pharmacists in the Medication Reﬁll Clinic
area as a part of a multidisciplinary team in which he/she can provide education to patients and
caregivers on the safe and appropriate use of medications, counsel on medication compliance, mon-
itor and manage medication side effects, as well as screen for dangerous drug interactions.Methods:
The data of this prospective, single-centered, chart review based study have been collected since the
clinic launched in June 2011 till December 2013 in King Khalid Eye Specialist Hospital which is a
Tertiary Hospital in KSA. Types of interventions documented during the patient–pharmacist visit
are categorized as medication review and patient compliance. Key ﬁndings: Out of the total 16,417
patients, 3641 (22.2%) are noncompliant. The Clinical Pharmacist identiﬁed 18 intervention types.
The most frequent interventions are as follows: Eye screening (24.8%), Counseling (13%),
Physician/ER referral (12.4%), Therapeutic substitution/switch (10.8%), and Frequency changed
(7%). Summary: This prospective analysis is a document evidence showing Clinical Pharmacist pos-
itive outcomes in the management of ophthalmic patients. Dissemination of this information would
be valuable because it could raise the awareness of other Healthcare Professionals regarding
Pharmacist as effective clinicians in care of ophthalmic patients.
ª 2015 Production and hosting by Elsevier B.V. on behalf of King Saud University. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Hospital Ambulatory Care Services – Outpatient Pharmacy
has a set of services provided to all Healthcare Providers in
the hospital and patients with appointment for the clinicsincluding emergency visits at King Khalid Eye Specialist
Hospital. Pharmacy Department’s vision and mission has been
established to be a reliably standard setting in its provision of
direct patient care and to continuously develop methods that
improve this practice. Scope of practice for Pharmacists has
expanded to pharmacist-managed health care clinics and col-
laborative practice arrangements with Physicians. The
Pharmacists have been safety consultants for patients with
minor illnesses and have assisted in important decisions
regarding medication reﬁlls. Based on all these factors, the idea
of Medication Reﬁll Clinic was initiated.
The role of Medication Reﬁll Clinic is to identify patients
that were not properly dosed and had high or low laboratoryal. Saudi
2 S.N. Alzuman, A.S. Al-Humaidanvalues; this is of paramount for patient care. The clinic is run
by Clinical Pharmacist who has very essential role in the
safety, quality and effective use of medications toward improv-
ing patient’s health in the hospital. Clinical Pharmacists in the
Reﬁll Clinic is a part of a multidisciplinary team in which
he/she provides education to patients and caregivers on the
safe and appropriate use of medications, counsel on
medication compliance, monitor and manage medication side
effects, as well as screen for dangerous drug interactions. A
Clinical Pharmacist is authorized to provide the following ser-
vices: (1) Write prescription renewal, (2) Prescribe certain new
medications (restricted to lubricants and over-the-counter
medications only), (3) Adjust therapy, (4) Order laboratories,
(5) Monitor patients (assess Intra Ocular Pressure
(IOP)/Visual Acuity (VA)), and (6) Request urgent follow-up
appointments.
There were a lot of studies that demonstrated the experi-
ence and the beneﬁt of Clinical Pharmacist to manage the reﬁll
program in different areas such as cardiac disease, diabetes
mellitus, and HIV. Unfortunately, the literature evidence of
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Pharmaceutical Journal (2015), http://dx.doi.org/10.1016/j.jsps.2015.07.002So, we extrapolate the principles for this clinic from the most
relevant ﬁelds such as HIV and VA Medication Reﬁll Clinics.
Due to the novelty of this clinic, there was a need to deter-
mine the utility of this practice model. The main outcomes of
this study are to evaluate the validity of Medication Reﬁll
Clinic in Ophthalmic Tertiary hospital setting and the role of
Clinical Pharmacist to determine the type of interventions that
can be made and whether this practice will improve the patient
compliance.2. Methodology
In this prospective study, the data had been collected since the
clinic launched in June 2011 till December 2013. The working
hours for the clinic were from 7:30 till 16:30 in the weekdays
only. The data had been collected during the study based on
patient’s charts review. The in-charge Clinical Pharmacist in
this clinic conducted all charts review throughout study
duration and was a certiﬁed eye screener (IOP, VA) at the
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Table 1 Inclusion and Exclusion Criteria.
Inclusion criteria Exclusion criteria
 Patient’s prescription written by a KKESH healthcare provider
 Patient must have been evaluated by a KKESH provider within the
past 12 months or who had not been evaluated for more than
12 months but have a ﬁx appointment for the next 3 months
 Prescribed medications must have originally been dispensed by
KKESH outpatient pharmacy and a KKESH formulary
medications
 The prescribed medications must be only intended for disease of the
eye
 Patient’s prescriptions written by a non-KKESH healthcare
provider
 Patients who have not been evaluated by a KKESH provider for
more than 12 months and/or has no ﬁx appointment within next
3 months, or who have missed 2 consecutive appointments, or
who have closed ﬁles due to service discharge or missed
appointments
 Prescribed medications have been dispensed from outside KKESH
hospital or it is not a KKESH formulary medications
 The prescribed medication not intended for disease of the eye
Figure 2 Type of interventions reported during the study for 3 years (2011, 2012, and 2013) and comparison of the rate between them
which show improve in patient compliance ex.: increase the number of patient counseling and decrease in patient eye screening from 2011
till 2013.
Clinical Pharmacist interventions 32.1. Request procedure
In order to get amedication reﬁll prescription, the patient has to ﬁll
a special request form called (Medication Reﬁll Request Form)
that provides the Clinical Pharmacist with concise information
about the patient while reviewing his chart. Then, the patient will
be called to the clinic for screening (IOP check, laboratory
requested)by theClinicalPharmacist before getting themedication
reﬁll prescription (Fig. 1). Medications that may not be reﬁlled
include the following: Decongestant unless Glaucoma,
Narcotics, Non-Ophthalmic Medications, and Non-Steroidal
Anti-inﬂammatory Drugs (NSAIDS) due to corneal breakdown.
All prescriptions written by a Clinical Pharmacist are valid
for two (2) weeks from the original date of issue, including
antibiotics for chronic prophylactic use only. All prescriptions
older than 2 weeks will not be considered.
2.2. Measurement tools
We measured the patient noncompliance in order to estimate
the patient compliance after initiating this service. ThePlease cite this article in press as: Alzuman, S.N., Al-Humaidan, A.S. Clinical Pharma
Pharmaceutical Journal (2015), http://dx.doi.org/10.1016/j.jsps.2015.07.002Noncompliance has been deﬁned as follows: any patient with
more than 1 year since the last appointment or has 2 missed
consecutive appointments. The inclusion and exclusion criteria
were developed based on type of patients who had been seen in
the clinic Table 1.
The collected data were recorded in data collection sheets
on daily basis and at the end of each month; the data have
been extracted into Excel intervention sheets in order to be
calculated using MS 2010 Excel sheets and SPSS. The medical
record number is the only way to identify the patient in daily
log sheet to preserve patient conﬁdentiality.
3. Results
3.1. Medication review interventions
There were 16,417 total patients seen in medication Reﬁll Clinic
from June 2011 to December 2013. Out of the total, 3641
(22.2%) were noncompliant. The Clinical Pharmacist identiﬁed
17 intervention types with a total 1164 intervention during the
study. The most frequent interventions are as follows: Eyecist interventions in Reﬁll Clinic at Tertiary Care Eye Specialist Hospital. Saudi
Table 2 Types of interventions and number of episode of each
event through the 3 years.
Interventions 2011 2012 2013 Sum
Allergy-drug interactions 4 7 11
Chronic drug restarted 21 48 11 80
Contraindication 1 1 2
Counseling 22 47 81 150
Dose-change (mg, mcg) 1 4 5
Drug–disease interaction 3 3
Duplication 3 4 7
Frequency changed 40 31 11 82
IOP taken 136 81 69 286
Laboratories order 32 38 8 78
New drug started 10 12 4 26
Physician referral/emergency room 73 20 50 143
Pregnant/Lactation (regimen changed) 9 10 2 21
Stopped drug 34 29 13 76
Therapeutic substitution/switch 31 78 16 125
Wrong drug 1 2 1 4
Wrong eye 33 18 14 65
Table 3 CI is improving by time.
Summary of the most important
statistical data
2011 2012 2013
Mean 34.72 54.00 53.00
Standard error 11.24 26.35 31.90
Standard deviation 47.68 105.40 119.36
Conﬁdence level (95.0%) 23.71 56.16 68.92
4 S.N. Alzuman, A.S. Al-Humaidanscreening (24.8%), Patient counseling (13%), Physician/ER
referral (12.4%), Therapeutic substitution/switch (10.8%),
and Frequency changed (7%) (Fig. 2); (Tables 2 and 3).
3.2. Patient’s compliance
The number of noncompliant patients who did not claim their
prescription in the validity period was 1153, and noncompliantFigure 3 Number of unclaimed prescriptions in 2011 is starting from
got more steady by 2013.
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Pharmaceutical Journal (2015), http://dx.doi.org/10.1016/j.jsps.2015.07.002patients who did not been seen for more than 1 year were 2483.
There was a decrease in number of patient who were not seen
for more than 1 year from 2011 to 45.9% compared to 2013.
The averages of noncompliance percentage due to unclaimed
prescription were (8.95%, 5.85%, and 8.50%) for the years
2011, 2012, and 2013 respectively Fig. 2. The averages of non-
compliance of patients whom not been seen for more than
1 year were 24.38%, 15.49%, and 8.57% for the same duration
respectively Fig. 3.4. Discussion
With the introduction of pharmacy ambulatory care services
to the pharmacy ﬁeld several decades ago, it has been proven
by time the positive effect of this service on patients by improv-
ing the quality of services and patient compliance through
direct patient care and medication management (Helling and
Johnson, 2014).
Pharmacists can be a valuable part of the patient care team
by providing medication review and patient education for dif-
ferent kind of diseases within clinics. Previous studies showed
that Clinical Pharmacist can promote optimal medication ther-
apy by addressing medication non-adherence, suboptimal
medication choices and cost ineffective therapies in ambula-
tory care services by working with different specialized health
care providers such as primary care physician, HIV and oncol-
ogy management clinics.
A shifting of paradigm in the practice and workﬂow in oph-
thalmology has been occurring in correspondence with the
advancement in the treatments and managements of eye dis-
eases. The role of Clinical Pharmacist in this area according
to the literature is still limited. Most of studies that had been
done regarding the Clinical Pharmacist role in ophthalmic ﬁeld
are focusing in patient compliance, medications errors or
patient counseling, but no study determines the role of
Clinical Pharmacist as interventionist within patient treatment
plan or discusses the type of interventions that can be made for
these type of patients. This kind of new clinical practice model
in ophthalmology ﬁeld can guide others on how to address
challenges or to assist in the development of similar models.June at the time the study been lunched. The ﬂuctuation in graph
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Figure 4 The percentage of patient whom not been seen for more than 1 year is decrease by time as pharmacist get more involved in
patient care.
Figure 5 Number of patient not been seen for more than 1 year reached the lowest by end of 2013.
Clinical Pharmacist interventions 5The privilege of Clinical Pharmacist to prescribe prescrip-
tion and perform eye screening was debatable. This privilege
was granted by the hospital authorities for the Clinical
Pharmacist based on the evidence that proved the success of
this practice especially in Canada and UK. In UK, making full
use of pharmacist independent prescribing has improved the
care of patient (Sassi-Jones, 2010). In Canada, pharmacist
writing a prescription is being practiced since a decade ago
(Law et al., 2012). As for eye screening performance, the hos-
pital authorities believe on the capabilities of Clinical
Pharmacists to be a member of multidisciplinary team
involved in patient’s care at different areas effectively such as
vaccination, diabetic clinic, anticoagulation clinic, and others.
These type of privileges enable pharmacists to independently
handle all or part of a patient visit, freeing up physicians toPlease cite this article in press as: Alzuman, S.N., Al-Humaidan, A.S. Clinical Pharma
Pharmaceutical Journal (2015), http://dx.doi.org/10.1016/j.jsps.2015.07.002treat more patients and attend to cases that fall outside of col-
laborative practice protocols.
There are many studies considering the different aspects of
Clinical Pharmacist interventions in ambulatory care clinics
have been published during the last few years. In our study
Eye Screening was the most common intervention that was
recorded during the study period. The Clinical Pharmacist
was able to maintain the patient or do intervention depending
on the patient situation as per eye screening result.
Patient Counseling was one of the most frequent interven-
tion that has been recorded in this clinic due to the lack of
patient physician follow-up visits especially for patients with
post-surgeries appointments (e.g. Penetrating Keratoplasty,
Cataract, Laminar Keratoplasty, etc), patients with big time
gap between the last visit and the next follow-up appointment,cist interventions in Reﬁll Clinic at Tertiary Care Eye Specialist Hospital. Saudi
6 S.N. Alzuman, A.S. Al-Humaidanand the patients who are living outside capital city and cannot
offer expenses of transportation. In addition, Physician/ER
referral, Therapeutic substitution/switch, and frequency
change interventions were implemented based on eye screening
results with or without labratory values. Wrong eye error was
observed in the ﬁnding with a total of 65 (5.6%) which is con-
sidered reasonable for a tertiary care institute.
Many clinics that specialize in the assessment and treat-
ment of ophthalmic patients have been suggested to have
more frequent follow-up visit through the year to improve
patient care. Yet, such clinics are often having long waiting
times (e.g. 6–12 months for specialized clinic in tertiary care
hospital) which is the main cause for patient noncompliance.
In Hoevenaars et al. study, the deﬁnition of non-compliance
(one missed dose in the past 4 weeks) (Hoevenaars et al.,
2008) which some considered is very unusual and very strict
but in Ngan et al.’s study, they deﬁned the non-adherence
as less than 1 year of follow-up, fewer than 2 completed
visual ﬁeld test, or both (Ngan et al., 2007) the authors
extrapolate from this deﬁnitions to create the deﬁnition of
noncompliance for this study. The medication reﬁll clinic
adjusts the compliance based on the number of patients
who had not been seen for more than 1 year which is
decreased from 1021 patients in 2011 to 552 patients in
2013 (45.9%) Figs. 4 and 5.
5. Study limitation
The clinic was not speciﬁed to special area. It was covering all
ophthalmic divisions (Glaucoma, Anterior Segment, Uveitis,
Retina, and Oculoplastics) with no prospect data concern each
specialty per se. Also, due to using patient medical records
number solely in our records for conﬁdentiality purposes, it
was so hard to collect clinical patient characteristics such as
age or gender.Please cite this article in press as: Alzuman, S.N., Al-Humaidan, A.S. Clinical Pharm
Pharmaceutical Journal (2015), http://dx.doi.org/10.1016/j.jsps.2015.07.0026. Conclusion
This prospective analysis is document evidence showing posi-
tive outcomes of Clinical Pharmacist interventions in the man-
agement of ophthalmic patients. Due to the novelty of
medication Reﬁll Clinic in ophthalmology setting, there was
a need to determine the utility of this practice model.
Dissemination of this information would be valuable because
it could raise the awareness of other Healthcare
Professionals regarding Clinical Pharmacist as a member in
health care team for ophthalmic patients. This increased
awareness could evaluate the proﬁle of Clinical Pharmacists
engaged in such activities. With recent patient-centered care
concept involving multidisciplinary teams, Clinical
Pharmacist participation in ophthalmic Medications Reﬁll
Clinics represents an expanded scope of practice of patient care
that will give a new direction to the involvement of pharmacist
in ophthalmic patient care.
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